CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab. de Vries Lentsch S, Al-Hassany L, Ferrari MD, Terwindt GM, et al. J Neurol Neurosurg Psychiatry 2022 Jan 27. pii: jnnp-2021-327992.

Read + Share

Amedeo Smart

Independent Medical Education

de Vries Lentsch S, Al-Hassany L, Ferrari MD, Terwindt GM, et al. CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab. J Neurol Neurosurg Psychiatry 2022 Jan 27. pii: jnnp-2021-327992.
PMID: 35086941